Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

46.16

+0.14 (0.30%)

At close: Mar 6, 2026, 4:00 PM EST

46.16

0.00 (0.00%)

After-hours: Mar 6, 2026, 5:08 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Developing and Delivering Therapeutic Medicines	677.56M	423.24M	270.26M	220.18M	38.54M
Developing and Delivering Therapeutic Medicines Growth	60.09%	56.60%	22.74%	471.24%	-
Total	677.56M	423.24M	270.26M	220.18M	38.54M
Total Growth	60.09%	56.60%	22.74%	471.24%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	676.75M	421.43M	269.77M	-	-
United States Growth	60.58%	56.22%	-	-	-
United Kingdom	814.00K	930.00K	487.00K	-	-
United Kingdom Growth	-12.47%	90.97%	-	-	-
Rest of World	-	875.00K	-	-	-
Bermuda	-	-	-	220.18M	38.54M
Bermuda Growth	-	-	-	471.24%	-
Total	677.56M	423.24M	270.26M	220.18M	38.54M
Total Growth	60.09%	56.60%	22.74%	471.24%	-

Source: S&P Global Market Intelligence.